n-(5-Chloro-1,3,4-thiadiazol-2-yl)acetamide, 97%, 100mg

2-Chloro-3,5-dimethoxyaniline, 95.0%, 5g

(3-(((tert-Butoxycarbonyl)amino)methyl)phenyl)boronic acid, 95.0%, 100mg

2,2-DIFLUOROMALONAMIDE, 95.0%, 500mg

Di(N-succinimidyl) 3,3-Dithiodipropionate [Cross-linking Reagent], 97.0%, 250mg

1,3-Dichloro-2,2-dimethoxypropane, 95.0%, 1g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 750m2/g)5g

1-Phenyl-but-2-en-1-one, 97.0%, 1g

6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 100mg

4-[4-(1,1-Dimethylethyl)phenyl]-1H-pyrazole, 5g

(3R)-3-Amino-azepane-1-carboxylic acid tert-butyl ester, 98.0%, 250mg

2-(3-(Dimethylamino)propoxy)-5-(trifluoromethyl)aniline, 95.0%, 250mg

2-(Trifluoromethyl)pyrimidin-5-amine, 95.0%, 1g